| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/03/2013 | EP2609932A2 Variant target binding agents and uses thereof |
| 07/03/2013 | EP2609811A1 Ice crystallization inhibitor derived from basidiomycetes |
| 07/03/2013 | EP2609237A2 Mechanically-activated cation channels |
| 07/03/2013 | EP2609119A1 Chitinous polysaccharide antigen binding proteins |
| 07/03/2013 | EP2609118A2 Anti-ox40 antibodies and methods of using the same |
| 07/03/2013 | EP2609117A1 Antibodies against il-18r1 and uses thereof |
| 07/03/2013 | EP2609116A1 Insect binding antibodies |
| 07/03/2013 | EP2609115A1 Compositions for seed treatment |
| 07/03/2013 | EP2609114A1 Hiv core protein specific antibodies and uses thereof |
| 07/03/2013 | EP2609113A1 Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin |
| 07/03/2013 | EP2609112A1 Activatable bispecific antibodies |
| 07/03/2013 | EP2609111A1 Bispecific antibodies comprising a disulfide stabilized - fv fragment |
| 07/03/2013 | EP2608808A2 Treatment for neoplastic diseases |
| 07/03/2013 | EP2608807A1 Notum protein modulators and methods of use |
| 07/03/2013 | EP2608803A2 Dual variable domain immunoglobulins and uses thereof |
| 07/03/2013 | EP2207809B1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 07/03/2013 | CN1360678B Method for early detection of flaviviruses using NS1 glycoprotein and application thereof |
| 07/03/2013 | CN103189392A ErbB3 binding antibody |
| 07/03/2013 | CN103189391A Novel antigen binding proteins |
| 07/03/2013 | CN103189390A Single unit ion exchange chromatography antibody purification |
| 07/03/2013 | CN103189385A Process for purifying proteins |
| 07/03/2013 | CN103189074A Methods of treating rheumatoid arthritis using IL-17 antagonists |
| 07/03/2013 | CN103184234A Tumor antigens BFA5 for prevention and/or treatment of cancer |
| 07/03/2013 | CN103184229A Recombinant protein A/G gene and preparation and application of expression product of recombinant protein A/G gene |
| 07/03/2013 | CN103183739A Novel antibodies inhibiting c-MET dimerization, and uses thereof |
| 07/03/2013 | CN103183738A Compositions and methods of use for antibodies of c-MET |
| 07/03/2013 | CN103183737A Anti-TOM22 protein monoclonal antibody and application thereof |
| 07/03/2013 | CN103183736A Anti-CLCN7 protein monoclonal antibody and application for same |
| 07/03/2013 | CN103183735A Anti-HIV genetic engineering divalent antibody and preparation method thereof, and anti-HIV genetic engineering medicine |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183725A A method of detecting protein lysine crotonylation acylation modification and developing affinity reagents |
| 07/03/2013 | CN102786598B Anti-ERCC1 monoclonal antibody 4F9 and application |
| 07/03/2013 | CN102532271B Brucella B cell epitope and monoclonal antibody and application thereof |
| 07/03/2013 | CN102432673B Brucella bp26 protein epitope, monoclonal antibody and application thereof |
| 07/03/2013 | CN101987870B Optimized Fc variants |
| 07/03/2013 | CN101965403B Composition for neutralizing botulinus toxin type-a, and human anti-botulinus toxin type-a antibody |
| 07/03/2013 | CN101948536B Porcine transmissible gastroenteritis virus (PTGEV) and porcine epidemic diarrhea virus (PEDV) dual yolk antibody and preparation method thereof |
| 07/03/2013 | CN101854946B Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers |
| 07/03/2013 | CN101839918B Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof |
| 07/03/2013 | CN101688204B Method for manufacturing a recombinant polyclonal protein |
| 07/03/2013 | CN101665536B Anti-vegf antibodies |
| 07/03/2013 | CN101655498B Immune colloidal gold test stripe for detecting leucomalachite green in aquatic product and preparation method |
| 07/03/2013 | CN101481406B H5 subtype avian influenza virus neutralization epitope peptide mimics and uses thereof |
| 07/03/2013 | CN101454343B Modified humanised anti-interleukin-18 antibodies |
| 07/03/2013 | CN101445555B Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 07/03/2013 | CN101023095B Genetic engineering protein P40 and application thereof |
| 07/03/2013 | CN101014625B Novel anti-IGF-IR antibodies and uses thereof |
| 07/02/2013 | US8476411 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 07/02/2013 | US8476410 Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof |
| 07/02/2013 | US8476409 Bispecific anti-IGF-1R and anti-ErbB3 antibodies |
| 07/02/2013 | US8476040 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 07/02/2013 | US8476033 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 07/02/2013 | US8476027 Detection of cannabis use |
| 07/02/2013 | US8476009 Methods for detecting enveloped virus infections by measuring cell surface TSG101 |
| 07/02/2013 | US8475799 HIV-1 GP41 neutralization domain and use thereof |
| 07/02/2013 | US8475797 Interferon alpha antibodies and their uses |
| 07/02/2013 | US8475796 Method of treating pain using an antagonist of GM-CSF |
| 07/02/2013 | US8475795 Anti-folate receptor alpha antibodies and uses thereof |
| 07/02/2013 | US8475794 Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies, Autoimmune disease and other diseases |
| 07/02/2013 | US8475793 Engineered anti-TSLPR antibodies |
| 07/02/2013 | US8475792 Molecules with extended half-lives, compositions and uses thereof |
| 07/02/2013 | US8475791 Anti-IL-TIF antibodies and methods of use |
| 07/02/2013 | US8475766 Dual specificity antibodies and methods of making and using |
| 07/02/2013 | CA2542044C Fully human antibodies against human 4-1bb (cd137) |
| 07/02/2013 | CA2533849C Aminated complex-type sugar chain derivatives and process for the production thereof |
| 07/02/2013 | CA2533559C Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof |
| 07/02/2013 | CA2501870C Single chain recombinant t cell receptors |
| 07/02/2013 | CA2478957C Homogentisate prenyl transferase ("hpt") nucleic acids and polypeptides, and uses thereof |
| 07/02/2013 | CA2438818C Rapid production of monoclonal antibodies |
| 07/02/2013 | CA2408302C Long wavelength engineered fluorescent proteins |
| 07/02/2013 | CA2401974C Dna expression vectors and methods of use |
| 07/02/2013 | CA2335376C Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 06/27/2013 | WO2013096847A1 Serum amyloid p-antibody fusion proteins |
| 06/27/2013 | WO2013096828A1 Surrogate binding proteins |
| 06/27/2013 | WO2013096812A1 Articles of manufacture and methods for co-administration of antibodies |
| 06/27/2013 | WO2013096732A2 Methods of treating or preventing viral diseases by blocking interleukin-21 |
| 06/27/2013 | WO2013096516A1 Methods for treating acne |
| 06/27/2013 | WO2013096346A1 Bispecific t-cell activator antibody |
| 06/27/2013 | WO2013096221A1 Variant fc-polypeptides with enhanced binding to the neonatal fc receptor |
| 06/27/2013 | WO2013096166A1 PSEUDOMONAS AERUGINOSA OprM EPITOPES FOR USE IN DIAGNOSTICS AND THERAPEUTICS |
| 06/27/2013 | WO2013096142A1 Humanized light chain mice |
| 06/27/2013 | WO2013095738A2 Monoclonal antibodies with altered affinities for human fcyri, fcyrllla, and c1q proteins |
| 06/27/2013 | WO2013095091A2 Rsv g protein specific antibodies |
| 06/27/2013 | WO2013094723A1 Novel anti-human ctgf antibody |
| 06/27/2013 | WO2013094080A1 Recombinant protein capable of specifically and rapidly binding to troponin-i originated from human cardiac muscles |
| 06/27/2013 | WO2013093809A1 Engineered antibody constant regions for site-specific conjugation and methods and uses therefor |
| 06/27/2013 | WO2013093762A1 Compositions and methods for antibodies targeting factor p |
| 06/27/2013 | WO2013093707A1 Human growth hormone receptor antagonist antibodies and methods of use thereof |
| 06/27/2013 | WO2013093693A1 Staphylococcus aureus specific antibodies and uses thereof |
| 06/27/2013 | WO2013093379A1 Novel pharmaceutical compositions comprising an antibody which binds the human anti-mullerian hormone receptor type ii |
| 06/27/2013 | WO2013093122A2 Antibodies for the treatment and diagnosis of affective and anxiety disorders |
| 06/27/2013 | WO2013092952A2 Method for selectively quantifying a-beta aggregates |
| 06/27/2013 | WO2013092875A1 Vaccines against hpv |
| 06/27/2013 | WO2013092743A2 Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides |
| 06/27/2013 | WO2013092720A1 Full length antibody display system for eukaryotic cells and its use |
| 06/27/2013 | WO2013092716A1 Rapid method for cloning and expression of cognate antibody variable region gene segments |
| 06/27/2013 | WO2013092001A1 Bispecific antibody molecule |
| 06/27/2013 | WO2013091903A1 Anti-crac channel antibodies |
| 06/27/2013 | WO2013091103A1 Single domain antibodies as inhibitors of pcsk9 |
| 06/27/2013 | WO2013090989A1 Method of treating inflammatory bowel disease |